# THORATEC CORP

THORATEC CORP is a company headquartered in Pleasanton, CA, United States.

## Company overview

- **Legal name:** THORATEC CORP
- **Former names in filing history:** THORATEC CARDIOSYSTEMS INC (2001-02-27 to 2001-02-26); THORATEC LABORATORIES CORP (1996-05-13 to 2001-02-09)
- **Classification:** Company
- **Industry (SIC):** 3845 — Electromedical & Electrotherapeutic Apparatus
- **Headquarters:** Pleasanton, CA, United States
- **Incorporated in:** CA
- **Fiscal year end:** December 28
- **SEC CIK:** 0000350907

## About

THORATEC CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000350907, and its reported industry is Electromedical & Electrotherapeutic Apparatus. In 10-K filed on 2015-02-19, it reported annual revenue of USD 477,560,000; net income of USD 50,391,000; total assets of USD 763,983,000 for the fiscal period ended 2015-01-03. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2014 (period ended 2015-01-03)

- **Revenue:** $477.6M (USD 477,560,000)
- **Net income:** $50.4M (USD 50,391,000)
- **Total assets:** $764.0M (USD 763,983,000)
- **Cash and equivalents:** $72.8M (USD 72,814,000)
- **Operating cash flow:** $90.8M (USD 90,766,000)

### FY2013 (period ended 2013-12-28)

- **Revenue:** $502.8M (USD 502,821,000)
- **Net income:** $73.3M (USD 73,326,000)
- **Total assets:** $791.7M (USD 791,707,000)
- **Cash and equivalents:** $139.1M (USD 139,099,000)
- **Operating cash flow:** $109.8M (USD 109,768,000)

### FY2012 (period ended 2012-12-29)

- **Revenue:** $491.7M (USD 491,654,000)
- **Net income:** $56.2M (USD 56,163,000)
- **Total assets:** $698.4M (USD 698,364,000)
- **Cash and equivalents:** $101.3M (USD 101,322,000)
- **Operating cash flow:** $139.5M (USD 139,538,000)

### FY2011 (period ended 2011-12-31)

- **Revenue:** $422.7M (USD 422,713,000)
- **Net income:** $71.5M (USD 71,544,000)
- **Total assets:** $681.0M (USD 680,988,000)
- **Cash and equivalents:** $42.7M (USD 42,661,000)
- **Operating cash flow:** $110.7M (USD 110,711,000)

## Recent SEC filings

- Form 8-K — filed 2015-10-08 — period 2015-10-07 — 8-K
- Form 8-K — filed 2015-10-08 — period 2015-10-05 — 8-K
- Form 8-K — filed 2015-10-01 — period 2015-09-30 — 8-K
- Form 8-K — filed 2015-08-31 — period 2015-08-28 — 8-K
- Form 10-Q — filed 2015-08-05 — period 2015-07-04 — 10-Q
- Form 8-K — filed 2015-08-04 — period 2015-08-04 — FORM 8-K
- Form 8-K — filed 2015-07-22 — period 2015-07-21 — FORM 8-K
- Form 10-Q — filed 2015-05-12 — period 2015-04-04 — 10-Q
- Form 8-K — filed 2015-05-08 — period 2015-05-05 — 8-K
- Form 8-K — filed 2015-05-07 — period 2015-05-07 — 8-K
- Form 8-K — filed 2015-04-27 — period 2015-04-27 — 8-K
- Form 8-K — filed 2015-04-08 — period 2015-04-06 — 8-K

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/thoratec-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology